Detailed Explanation
The maximum tolerated dose represents a critical milestone in drug development, defining the upper boundary of the tolerable dose range for an investigational product. Identified through systematic dose escalation studies, the MTD serves as a key reference point for selecting doses in subsequent efficacy trials. For oncology drugs and other treatments where efficacy may correlate with dose, the MTD often becomes the recommended Phase II dose, though modern development increasingly emphasizes optimal biological dosing over maximum tolerated dosing.